Opko Health, Scripps Institute Developing Antibody-Based Alzheimer's Diagnostic
January 07, 2011
Opko Health, Scripps Institute Developing Antibody-Based Alzheimer's Diagnostic
The diagnostic is being developed using a new peptoid-based technique for detecting disease-specific antibodies that could prove broadly useful as a protein biomarker discovery tool, said a researcher.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Initial Analysis of ADNI Plasma Proteome Data Suggests Possible Protein Signatures for Alzheimer's
December 10, 2010 / ProteoMonitor - Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor - Penn Researchers ID Acetylated Tau as Potential Protein Biomarker for Alzheimer's, Related Disorders
April 8, 2011 / ProteoMonitor - Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor - AD Working Group Proposes New Alzheimer's Definition to Include Protein Biomarkers
October 15, 2010 / ProteoMonitor